{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifibjmaiyjyagepzweg2scplsx7q5kmlxht23hllm3n36ixmkwpp4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mkbpp57ym2a2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiasjalwemy5s4qol3g5xzf5a3lhdq43j4uzl6i2bwszq6u6u4bbp4"
    },
    "mimeType": "image/jpeg",
    "size": 129679
  },
  "path": "/news/2026-04-phage-therapy-case-reveals-hidden.html",
  "publishedAt": "2026-04-24T19:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The Alfred and Monash University. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.",
  "title": "Phage therapy case reveals hidden antibodies can block treatment of drug-resistant infections"
}